Stifel Financial Corp grew its holdings in ... Other hedge funds have also made changes to their positions in the company. Wellington Management Group LLP grew its holdings in shares of Vital ...

Stifel Nicolaus currently has a buy rating ... acquiring an additional 7,155 shares during the last quarter. Finally, Wellington Management Group LLP increased its stake in Abeona Therapeutics ...

It seems far too easy to blame the president for the stock market’s bad week. It wasn’t President Trump who rushed in to buy ...

Abbott Laboratories is basking in bullish analyst sentiment with a consensus rating of “Moderate Buy” from nineteen analysts currently covering the company. Four issued a “hold” recommendation, while ...

According to Roberts’ BrokerCheck profile, Stifel Nicolaus & Co., the broker-dealer arm of the holding company, settled one investor claim related to Roberts in February for $205,000 ...

Stifel Financial Corp.’s broker-dealer unit has seen yet another unfavorable outcome in an industry dispute, and on Friday a three-person arbitration panel ruled Stifel Nicolaus & Co. Inc. pay $ ...

On May 24, analysts at Stifel reaffirmed their Buy rating and price target of $48 for Bicara Therapeutics Inc. (NASDAQ:BCAX). This follows the American Society of Clinical Oncology (ASCO ...